Gimme Care Review
Best for: affordable compounded GLP-1 with nationwide coverage and microdose options
Gimme Care offers compounded semaglutide ($130–$160/mo) and compounded tirzepatide ($163–$199/mo) including microdose options. LegitScript verified. Available in all 50 states + DC. No membership fees.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Gimme Care is a solid telehealth option with balanced features and pricing.
Gimme Care at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $130/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Gimme Care
Each dimension is scored algorithmically from Gimme Care’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.3/10At $130/mo, Gimme Care runs about 24% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.0/10Gimme Care offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 5 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-05).
Accessibility10%
8.1/10Gimme Care treats patients in all 50 states.
Support10%
5.7/10Gimme Care provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Gimme Care review
Last checked 2026-06-05- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Gimme Care offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Gimme Care's current pricing and active discounts before you decide.
What we like
- All 50 states + DC coverage — broadest availability in the dataset
- LegitScript verified
- Both semaglutide and tirzepatide in compounded formats
- Microdose options available for both drugs
- No membership fees — price includes medication, physician, support, shipping, and supplies
- Multi-month discount: semaglutide $130/mo on 3-month plan
Watch-outs
- Five states require video/audio visits (KS, LA, MS, NM, WV)
- Compounded only — no brand-name options
- Also offers anti-aging treatments (NAD+, Sermorelin, Glutathione)
Gimme Care: the rare provider that actually covers all 50 states
If you live somewhere that most compounded-GLP-1 services quietly skip, Gimme Care is worth a hard look. Its single biggest selling point is reach: it ships to all 50 states plus the District of Columbia, the broadest footprint of any provider in our dataset. Pair that with a flat $130 a month starting price for compounded semaglutide and no membership fee, and you have a service built for people who want the lowest realistic out-of-pocket cost without jumping through residency hoops. It is not a luxury concierge experience, and it is not for anyone who needs brand-name Wegovy or Zepbound — but for cash-pay compounded therapy, it is one of the cleaner offers we have reviewed.
How the pricing actually works — and why 'flat' matters
Most GLP-1 telehealth pricing climbs as your dose climbs. Gimme Care does the opposite: it charges the same price at every dose. That is a genuinely patient-friendly structure for a class of drugs where you titrate upward over months. On a typical model you would pay more in month four than in month one simply because the milligrams went up; here the number stays put.
The headline rate is $130 a month for compounded semaglutide when you commit to a three-month plan billed in one charge every three months. Prefer to pay month to month? It runs a little higher — in the low-one-hundreds rather than the $130 tier — so the discount for committing up front is modest but real. Compounded tirzepatide sits a notch above semaglutide, in the mid-to-high-one-hundreds depending on whether you take the quarterly or monthly plan. For context, the category median in our data is $170 a month, so Gimme Care lands comfortably below the middle of the pack.
Crucially, that price is genuinely all-in. Gimme Care states the cost includes the medication, physician care, ongoing support, shipping, and all injection supplies — with no hidden fees and no membership cost layered on top. There is no separate consult charge and no annual platform fee to track, which is where a lot of 'cheap' competitors quietly make their margin back.
What you get and how it's dispensed
Gimme Care offers compounded semaglutide and compounded tirzepatide — the two active ingredients behind the best-known weight-loss injectables — plus microdose options for both. Microdosing is the standout here. Many providers only sell standard titration ladders; offering deliberately low-dose protocols gives people who are sensitive to side effects, or who simply want to start gently, a real path to ease in. Everything ships from licensed US facilities with free shipping built into the price.
- Compounded semaglutide, flat monthly price at every dose
- Compounded tirzepatide for those who want the dual-action option
- Microdose protocols for both drugs — useful for slow starters and the side-effect-sensitive
- Medication, clinician care, supplies, and shipping bundled into one price
- No membership or platform fee
The all-50-states claim, with one honest asterisk
The nationwide coverage is real, but read the fine print. In five states — Kansas, Louisiana, Mississippi, New Mexico, and West Virginia — Gimme Care requires a live video or audio visit rather than a purely asynchronous questionnaire. That is not a downside so much as those states' telehealth rules, and arguably it is a sign the company follows them rather than skirting them. If you live in one of those five, just plan for a short scheduled visit instead of a fully self-serve signup.
Trust and oversight: solid, with the usual compounding caveat
Gimme Care is LegitScript verified, which is the certification we look for to confirm a telehealth pharmacy operation is legitimately licensed and monitored — a meaningful signal in a space crowded with fly-by-night sellers. We found no FDA warning letters on file for this provider, and the company is transparent about its pricing and inclusions, which we always read as a good-faith marker. You can see how we weigh these factors in our scoring methodology.
That said, the standard compounded-GLP-1 caveat applies and we will not soft-pedal it: compounded semaglutide and tirzepatide are not FDA-approved finished products the way Wegovy, Ozempic, and Zepbound are. They are mixed by compounding pharmacies, and the quality bar depends on the pharmacy and your prescriber. Gimme Care's LegitScript status and licensed-facility shipping are reassuring, but if FDA-approved branded medication is non-negotiable for you, this is not your provider — it is compounded only, with no brand-name rows.
Who should choose it — and who should skip it
Choose Gimme Care if you are paying cash, want the lowest sustainable monthly cost, value a price that won't creep up as your dose increases, and especially if you live somewhere other services refuse to ship. The microdose options make it a smart pick for anyone nervous about nausea or wanting to start conservatively.
Skip it if you need brand-name medication, if your insurance would cover an approved GLP-1 and you would rather use that, or if you want a high-touch concierge program with a dedicated coach. One small thing to keep in mind: Gimme Care also markets anti-aging treatments like NAD+, Sermorelin, Glutathione, B12, and MIC. That is not a red flag, but it does signal a provider with a broader menu rather than a laser focus on weight management — worth knowing if you want a service that does one thing.
Bottom line
Gimme Care is a no-nonsense, low-cost compounded GLP-1 service that wins on two things almost nobody else matches: genuine 50-state-plus-DC coverage and a flat price that doesn't punish you for titrating up. Add LegitScript verification, microdosing, and an all-inclusive $130-a-month starting rate that beats the $170 category median, and it earns a confident recommendation for cash-pay patients — provided you are comfortable with compounded rather than brand-name medication.
For a side-by-side, Found ($129/month) and Oak ($130/month) are the most comparable options to weigh against Gimme Care.
Ready to start with Gimme Care?
Starting at $130/month. See current pricing and start your free consultation.
Gimme Care might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Gimme Care
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Gimme Care review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Gimme Care?
Starting at $130/month. See current pricing and start your free consultation.